593 related articles for article (PubMed ID: 36960074)
1. Roles and therapeutic implications of m6A modification in cancer immunotherapy.
Pan J; Huang T; Deng Z; Zou C
Front Immunol; 2023; 14():1132601. PubMed ID: 36960074
[TBL] [Abstract][Full Text] [Related]
2. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
3. The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.
He C; Teng X; Wang L; Ni M; Zhu L; Liu J; Lv W; Hu J
Mol Biol Rep; 2023 Oct; 50(10):8691-8703. PubMed ID: 37598390
[TBL] [Abstract][Full Text] [Related]
4. Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy.
Liu W; Liu C; Wang H; Xu L; Zhou J; Li S; Cheng Y; Zhou R; Zhao L
Comput Struct Biotechnol J; 2022; 20():5150-5161. PubMed ID: 36187919
[TBL] [Abstract][Full Text] [Related]
5. Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer.
Zhang Y; Ling Y; Zhou Y; Shi X; Shen F; Zhou J; Chen Y; Yang F; Gu Y; Wang J
Cancer Control; 2024; 31():10732748241256819. PubMed ID: 38755968
[TBL] [Abstract][Full Text] [Related]
6. The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors.
Tong H; Wei H; Smith AO; Huang J
Front Immunol; 2021; 12():802049. PubMed ID: 35069586
[TBL] [Abstract][Full Text] [Related]
7. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
Fang F; Wang X; Li Z; Ni K; Xiong C
Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine RNA modification in PD-1/PD-L1: Novel implications for immunotherapy.
Luo P; Li S; Long X
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188873. PubMed ID: 36842764
[TBL] [Abstract][Full Text] [Related]
10. Research progress of N6-methyladenosine in colorectal cancer: A review.
Lin Y; Shi H; Wu L; Ge L; Ma Z
Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
[TBL] [Abstract][Full Text] [Related]
11. Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy.
Zhou X; Li C; Chen T; Li W; Wang X; Yang Q
Mol Cancer; 2023 Feb; 22(1):36. PubMed ID: 36810108
[TBL] [Abstract][Full Text] [Related]
12. The potential role of m6A modifications on immune cells and immunotherapy.
Gan L; Zhao Y; Fu Y; Chen Q
Biomed Pharmacother; 2023 Apr; 160():114343. PubMed ID: 36758318
[TBL] [Abstract][Full Text] [Related]
13. Targeting RNA N
Li W; Hao Y; Zhang X; Xu S; Pang D
Mol Cancer; 2022 Sep; 21(1):176. PubMed ID: 36071523
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine modification participates in neoplastic immunoregulation and tumorigenesis.
Zhao W; Li J; Ma Q; Cai J; Li A; Wu W; Lv Y; Cai M
J Cell Physiol; 2022 Jul; 237(7):2729-2739. PubMed ID: 35342948
[TBL] [Abstract][Full Text] [Related]
15. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic Roles of m6A Modification in Viral Infection and Virus-driven Carcinogenesis.
Wang JF; Cai W; Qiu FS; Yu CH
Endocr Metab Immune Disord Drug Targets; 2022; 22(10):1009-1017. PubMed ID: 35418293
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus.
Jayasree PJ; Dutta S; Karemore P; Khandelia P
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37831403
[TBL] [Abstract][Full Text] [Related]
18. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
Front Immunol; 2021; 12():773570. PubMed ID: 34956201
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modification of m
Wang Y; Wang Y; Patel H; Chen J; Wang J; Chen ZS; Wang H
Mol Cancer; 2023 Jun; 22(1):102. PubMed ID: 37391814
[TBL] [Abstract][Full Text] [Related]
20. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]